DrugPatentWatch Database Preview

Nextwave Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for NEXTWAVE PHARMS, and what generic alternatives to NEXTWAVE PHARMS drugs are available?

NEXTWAVE PHARMS has one approved drug.

There are seven US patents protecting NEXTWAVE PHARMS drugs.

There are thirty-four patent family members on NEXTWAVE PHARMS drugs in fourteen countries.

Summary for Nextwave Pharms

International Patents:	34
US Patents:	7
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Nextwave Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nextwave Pharms	QUILLICHEW ER	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE, CHEWABLE;ORAL	207960-001	Dec 4, 2015		RX	Yes	No	9,844,544		Y
Nextwave Pharms	QUILLICHEW ER	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE, CHEWABLE;ORAL	207960-001	Dec 4, 2015		RX	Yes	No	10,857,143		Y
Nextwave Pharms	QUILLICHEW ER	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE, CHEWABLE;ORAL	207960-002	Dec 4, 2015		RX	Yes	No	10,857,143		Y
Nextwave Pharms	QUILLICHEW ER	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE, CHEWABLE;ORAL	207960-001	Dec 4, 2015		RX	Yes	No	9,295,642		Y

International Patents for Nextwave Pharms Drugs

Country	Patent Number	Estimated Expiration
Spain	2721900
Brazil	112015003120
Canada	2880456
World Intellectual Property Organization (WIPO)	2014028610

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Nextwave
• Nextwave Pharms